Traumatic injury is associated with an increased risk of coagulopathy and venous thrombosis. plasminogen activator inhibitor-1 (PAI-1) is a procoagulant molecule that inhibits tPA/uPA, thrombomodulin, and activated protein C. We hypothesized that elevated PAI-1 levels would be associated with increased Injury Severity Score (ISS) in injured patients with and without traumatic brain injury and that PAI-1 levels would vary with injury type.
I njured patients suffer significant complications related to both hypocoagulability and hypercoagulability. Hemorrhage is most common cause of early preventable death following traumatic injury, while venothrombotic events typically occur after hemorrhage has been controlled. 1, 2 Approximately one in four traumatically injured patients presents with coagulopathy of trauma, which is associated with a fivefold increase in mortality. 3 Coagulopathy of trauma involves perturbations in both clot initiation and fibrinolysis, both of which have been shown to markedly impact outcomes in injured patients. 2, 3 Aberrant fibrinolysis plays a key role in the coagulopathy of trauma and confers a significant increase in the risk of death. 3, 4 Accurate characterization of the role of specific components of coagulation and fibrinolytic pathways in trauma patients remains elusive. The role of plasminogen activator inhibitor-1 (PAI-1) in traumatic hyperfibrinolysis and fibrinolytic shutdown remains a topic of active debate. Plasminogen activator inhibitor-1 is a powerful procoagulant via its inhibition of tPA/uPA, thrombomodulin, and activated protein C. Studies focusing on its role in atherosclerosis and metabolic syndrome have shown that PAI-1 is released by platelets as well as endothelium in response to inflammation, damage, or ischemia. [5] [6] [7] [8] Considerable debate continues as to the role of PAI-1 in coagulopathy of trauma, with some researchers advocating for a model of PAI-1 peak and consumption as a major cause of coagulopathy 3, 9 and others advocating for a model labeling PAI-1 as a bystander to more important perturbations of the coagulation and fibrinolytic cascades. 10 Based on these observations, we examined the association between admission PAI-1 levels and injury severity to determine if PAI-1 is proportional to burden of traumatic injury. We hypothesized that admission PAI-1 levels would be positively associated with Injury Severity Score (ISS). 11 Because there are likely differences in the degree of endothelial and platelet perturbation between multiple injuries, isolated body trauma, and isolated head trauma, we further predicted that these discrete injury patterns would have different PAI-1 levels.
METHODS
We conducted a post hoc analysis of prospectively collected data from the Fever and Inflammation in NeuroTrauma study, the methods of which have been published elsewhere, but are briefly summarized here. 12 Trauma patients presenting to Oregon Health and Science University with injury sufficient to warrant intensive care unit (ICU) admission from October 2013 through June 2015 were approached for informed consent. Patients refusing consent, that could not be consented, or who were not admitted to the ICU were excluded. See Figure 1 for a flow diagram detailing subject enrollment and exclusion. For patients with severe brain injury who were unable to provide informed consent themselves, consent was obtained from the patient's legally authorized representative. If and when they regained the ability to provide consent during the hospitalization, the patient was approached to reaffirm consent.
Demographic, laboratory, and hemodynamic data were collected from the medical record on the 268 enrolled patients. Abbreviated Injury Scale (AIS) scores for each body region and overall ISS were abstracted from the trauma registry (Table 1) .
Injury patterns were classified based on AIS score for different regions. Multiple injuries was defined as AIS head score greater than 2 with one other AIS region score greater than 2. Isolated body was defined as only one nonhead region with AIS score greater than 2, excluding head/face. Isolated head was defined as AIS head score greater than 2 and all other regions score less than 3. Minor injury was defined as no region with AIS score greater than 2; these patients were excluded from further analyses. Hypotension was defined as systolic blood pressure less than 90 mm Hg in the field or on upon arrival to the emergency department. Early transfusion was defined as receipt of packed red blood cell transfusion during the first 48 hours following arrival to the emergency department.
Plasma samples were obtained on admission (<8 hours from the trauma) and banked at −80°C for subsequent analysis. Plasma was analyzed using a Luminex human analyte platform that screens 63 secreted proteins using multiplex fluorescent immunoassay. Because PAI-1 levels were positively skewed, they were log transformed for all analyses (see Figure Descriptive statistics (median and interquartile range [IQR] for continuous variables; frequencies and percentages for categorical variables) were used to describe clinical data. Group comparisons for categorical variables were performed using Fisher's exact tests. Ordinal comparisons were made with the Wilcoxon-Mann-Whitney U-test for two group comparisons, and the Kruskal-Wallis H test for three group comparisons. Nonparametric methods were used for ordinal data and continuous data that were highly skewed. The association between PAI-1 and ISS was evaluated with analysis of variance and correlation analysis. A multivariate model was constructed for predicting ISS from PAI-1 that included all significant factors identified on univariate analysis. Statistical analyses were performed using 
RESULTS

Patient Characteristics
Five hundred ten patients met the criteria for screening, of whom 268 were enrolled, making up the population for this study. Reasons for not enrolling included 136 refusals of consent, 59 patients who did not require ICU admission, and 11 patients who expired prior to being approached for consent. Within our study population, the majority of patients were male (72%), white (88%), had a mean platelet count at admission of 227 (SD = 82), and had sustained major traumatic injury (28% ISS ≤ 15, 64% ISS = 16-34, 13% ISS ≥ 35). Hypotension was observed in 22% of patients in the field or upon presentation, and 22% were positive for ethanol. Twenty percent of patients underwent transfusion within 48 hours of presentation, and 8% showed evidence of coagulopathy as evidenced by international normalized ratio (INR) >1.5. Twenty-two percent of the patients were classified as multiple injuries, 37% were classified as isolated body, 36% were classified as isolated head, and 4% as minor injury.
Univariate Analysis
The PAI-1 levels were positively associated with increasing ISS (p < 0.0001). Additionally, PAI-1 was significantly higher in patients with ISS greater than 35 (p < 0.0001) but were not significantly different between patients with ISS of 15 or less and 16 to 34 (p = 0.1833, Fig. 2) .
The PAI-1 levels varied significantly by injury pattern (p < 0.0001). Multiple injuries patients had the highest PAI-1 levels with a mean of 6,766 pg/mL (SD = 3,156 pg/mL), followed by isolated body with a mean of 6,053 pg/mL (SD = 3,008 pg/mL) and isolated head with a mean of 4,820 pg/mL (SD = 2,163 pg/mL) pg/mL. There was no detectable association between mechanism of injury and PAI-1 level (p = 0.7422); however, only 6% of our study population had a penetrating mechanism. Admission INR was not associated with PAI-1 level (p = 0.6309) or with ISS (p = 0.6117), although patients with multiple injuries did have higher median INR (1.1; IQR, 1.02-1.24]) than those with isolated body (1.06; IQR, 1.01-1.18) or isolated head injuries (1.03; IQR,0.98-1.14) (p = 0.033).
On univariate analysis, age (p = 0.0011), hypotension (p = 0.0076), and alcohol intoxication (p = 0.0024) were all positively associated with PAI-1 level (Table 2 ). Within patients who did have a positive alcohol screen, there was no significant association between the ethanol level and PAI-1 level (p = 0.8982). Admission platelet level was not associated with PAI-1 level (p = 0.8426). There was a trend in patients requiring early transfusion toward having higher PAI-1 levels, though this association did not meet threshold for significance (p = 0.0672). There was not a meaningful association between BMI and PAI-1 level (p = 0.0256, but with correlation coefficient of 0.0186). The PAI-1 level was not associated with mortality (p = 0.5626).
There were differences in the strength of association between PAI-1 levels and ISS based on injury pattern (Fig. 3) . Patients with multiple injuries demonstrated the strongest relationship between ISS and admission PAI-1 levels (Pearson's pairwise correlation = 0.5511, p < 0.0001). Patients with isolated body trauma also displayed a significant association between ISS and admission PAI-1 levels, although less so than the multiple injuries group (Pearson's pairwise correlation = 0.2211, p = 0.0282). Patients with isolated head trauma demonstrated no significant relationship between ISS and admission PAI-1 levels (Pearson's pairwise correlation = 0.1469, p = 0.1546).
Multivariate Regression Analysis
A multivariate model for ISS was constructed that included all factors significantly associated with PAI-1 level on univariate analysis (see Table 3 ). Because it was not associated with ISS or PAI-1 level, INR was not included in this model. After adjusting for age, sex, hypotension, and alcohol intoxication, higher PAI-1 levels remained associated with higher ISS (p < 0.0001). Additionally, a significant interaction was observed between hypotension and admission PAI-1 level (p = 0.0043).
DISCUSSION
Injury burden varies significantly in patients presenting to trauma centers and early determination of injury severity for risk stratification remains problematic. The ISS is the most commonly used injury scoring system; however, ISS has significant limitations. Because ISS relies on both injury characterization and outcome data, 11 it can only be calculated retrospectively and cannot be used for early patient stratification. Additionally, as ISS includes outcomes, a compelling argument has been made that ISS is subject to inflation in the event of patient mismanagement. 13 For these reasons, an early marker that reflects injury burden and does not require injury and outcome data would be clinically and academically useful.
As there are likely differences in the amount of endothelial damage between patients with multiple injuries, isolated body trauma, and isolated head trauma, we hypothesized that not only would PAI-1 have a positive association with ISS, but also that these injury patterns would have different PAI-1 levels. This is, in fact, what we found. In previous studies involving trauma patients, a pattern of an initial spike in PAI-1 followed by a profound decline 4 has prompted investigators to question if PAI-1 is driving coagulopathy of trauma, or if PAI-1 is incidentally perturbed in patients with coagulopathy of trauma. It has been hypothesized that the increase in PAI-1 mobilization leads to a consumptive coagulopathy as tPA binds to and inactivates PAI-1, possibly followed by a compensatory increase in PAI-1 expression. 3, 9, 14, 15 In contrast, total PAI-1 levels have been observed to be similar between hyperfibrinolytic trauma patients and healthy controls, while the tPA/PAI-1 ratios was higher in patients with hyperfibrinolysis. 10 This observation suggests that it is a marked increase in tPA rather than consumption of PAI-1 that leads to hyperfibrinolysis following traumatic injury. Moreover, while a range of fibrinolysis phenotypes have been identified in coagulopathic trauma patients, these phenotypes as of yet have not been shown to associate with injury pattern. 16 In this study, we found that higher PAI-1 levels on admission are associated with increasing ISS in trauma patients with injuries sufficient to necessitate ICU admission. Further, the PAI-1 elevation was more pronounced in patients with hypotension. This aligns with prior studies that demonstrate that hypoperfusion and inflammation can result in increases in PAI-1. 5 Our finding that higher PAI-1 levels are associated with greater injury severity is consistent with and support the emerging belief that elevations in PAI-1 are a function of endothelial damage, platelet activation, and ischemia rather than strictly being a reflection of perturbations in the rest of the coagulation cascade.
The interaction between hypotension and PAI-1 is worth additional consideration. The association between PAI-1 and ISS is stronger in patients with hypotension. Coagulopathy of trauma has previously been shown to vary by injury pattern. This includes both differences in rate 17, 18 as well as potentially different mechanisms. In one study, hypoperfusion was shown to be a prerequisite for the development of activated protein C-mediated coagulopathy in patients with isolated head injury, 19 which is not typical of other injury patterns. Our results support the idea that altered perfusion can play an important role in influencing induction of fibrinolysis. Careful prospective study is needed to further delineate differences in coagulopathy between patients with and without isolated traumatic brain injury.
The relationship between ISS and PAI-1 that we observed was also different based on injury pattern (multiple injuries, isolated body, or isolated head). Patients with multiple injuries would be expected to have more endothelial damage than those with isolated body injury and isolated head injury. We suspect that this finding is reflective of PAI-1 level being reflective of level of endothelial damage. We are aware of one study that examined the relationship between PAI-1 and injury pattern have found no association 20 between the two. Additional study is needed to further clarify the etiology of the difference in findings, which may be explained by our larger sample size or differences in our study population. Furthermore, future evaluation should examine the relationship between PAI-1 and clinical outcomes to further clarify the role of PAI-1 in injury.
Our study has several important limitations. First, this was a post hoc analysis using a database created to study the association between inflammation and fever, which did not focus on coagulopathy. We did examine for associations between PAI-1 level or ISS with the best marker of coagulopathy that we had for these patients (INR), and none was detected; however, INR has been shown to poorly correlate with coagulopathy of trauma. 21 Additional measures of endothelial damage or platelet activation were not characterized, and thromboelastography was not performed. This precludes us from further examining the relative contribution of fibrinolysis and other components of the coagulation pathway on PAI-1 elevation. Finally, we did not examine subject use of medications, such as ACE inhibitors or hormone replacement therapy which have been shown to have indirect PAI-1 antagonist activity. 22 Elevated PAI-1 at admission is associated with higher ISS. This association is more pronounced in patients with hypotension. These findings suggest that PAI-1 levels may reflect the burden of endothelial damage after injury. If our findings can be confirmed, PAI-1 may serve as a useful, early marker of injury burden in trauma patients. AUTHORSHIP M.C. participated in the literature search, data analysis, data interpretation, writing, critical revision. S.R. participated in the data analysis, data interpretation, critical revision. E.D. participated in the data analysis, critical revision. T.A. participated in the literature search, critical revision. L.L. participated in the data collection. D.F. participated in the data interpretation, critical revision. H.H. participated in the study design, data collection, data analysis, data interpretation, critical revision.
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